Background: Activation of receptor tyrosine kinases is common in Malignancies. FGFR3 fusion with TACC3 has been reported to have transforming effects in primary glioblastoma and display oncogenic activity in vitro and in vivo. We set out to investigate the role of FGFR3 in glioma through transcriptomic analysis. Results: FGFR3 increased in Classical subtype and Neural subtype consistently in CGGA and TCGA cohort. Similar patterns of FGFR3 distribution through subtypes were observed in CGGA and TCGA samples. Gene ontology analysis was performed with genes that were significantly correlated with FGFR3 expression. We found that positively associated biological processes of FGFR3 were focused on differentiated cellular functions and neuronal activities, while negatively correlated biological processes focused on mitosis and cell cycle phase. Clinical investigation showed that higher FGFR3 expression predicted improved survival for glioma patients, especially in Proneural subtype. Moreover, FGFR3 showed very limited relevance with other receptor tyrosine kinases in glioma at transcriptome level. Materials and Methods: FGFR3 expression data of glioma was obtained from Chinese Glioma Genome Atlas (CGGA) and TCGA (The Cancer Genome Atlas). In total, RNA sequencing data of 325 glioma samples and mRNA microarray data of 301 samples from CGGA dataset were enrolled into this study. To consolidate the findings that we have revealed in CGGA dataset, RNA-seq data of 672 glioma samples from TCGA dataset were used as a validation cohort. R language was used as the main tool to perform statistical analysis and graphical work. Conclusions: FGFR3 expression increased in classical and neural subtypes and was associated with differentiated cellular functions. FGFR3 showed very limited correlation with other common receptor tyrosine kinases, and predicted improved survival for glioma patients.
第一作者机构:[1]Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China;[2]Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China;[6]Chinese Glioma Genome Atlas Network CGGA, Beijing, Peoples R China
通讯作者:
通讯机构:[1]Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China;[2]Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China;[4]Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing, Peoples R China;[5]China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China;[6]Chinese Glioma Genome Atlas Network CGGA, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Wang Zheng,Zhang Chuanbao,Sun Lihua,et al.FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients[J].ONCOTARGET.2016,7(51):84587-84593.doi:10.18632/oncotarget.13139.
APA:
Wang, Zheng,Zhang, Chuanbao,Sun, Lihua,Liang, Jingshan,Liu, Xing...&Jiang, Tao.(2016).FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients.ONCOTARGET,7,(51)
MLA:
Wang, Zheng,et al."FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients".ONCOTARGET 7..51(2016):84587-84593